|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$31.23 0.00 (0.00%) as of 4:30 Thu 2/8
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
38 |
|
|
Total
Direct Shares :
|
16,371,685 |
|
Total
Indirect Shares :
|
0 |
|
%
Held by Insiders:
|
6.18% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Zbi Equities, L.l.c. |
10% Owner |
2008-06-20 |
9,046,200 |
|
0 |
Korsant Philip B |
10% Owner |
2009-07-31 |
5,525,200 |
2009-07-31 |
0 |
Sayare Mitchel |
Director |
2011-07-29 |
383,136 |
2004-06-07 |
0 |
Gregory Richard J. |
Executive VP & CSO |
2019-01-07 |
236,056 |
|
0 |
Junius Daniel M |
Director |
2018-03-16 |
184,987 |
2007-08-15 |
0 |
Johnston David Brannon |
Chief Financial Officer |
2018-06-06 |
180,690 |
2015-08-03 |
0 |
Barrows Craig |
Executive VP, General Counsel |
2020-02-24 |
145,275 |
|
0 |
Blattler Walter |
Former Executive SVP |
2007-06-04 |
124,900 |
2004-06-07 |
0 |
Lambert John |
Executive Vice President |
2016-11-02 |
120,521 |
2004-06-07 |
0 |
Berkenblit Anna |
|
2023-06-30 |
113,935 |
|
0 |
Ryll Thomas |
SVP, Technical Operations |
2021-06-30 |
84,714 |
|
0 |
Shire Pharmaceuticals Group Plc |
10% Owner |
2004-06-02 |
66,098 |
|
0 |
Williams Peter J. |
VP, Business Development |
2017-02-23 |
50,620 |
2017-02-23 |
0 |
Foster David G |
V.P.-Fin., Prin. Acctg. Off. |
2020-12-31 |
38,274 |
2019-01-03 |
0 |
Morris Charles Q |
Executive VP & CDO |
2015-11-27 |
27,090 |
|
0 |
Harrington-Smith Kristen |
|
2022-11-15 |
25,000 |
2022-11-15 |
0 |
Skaletsky Mark B |
Director |
2004-07-01 |
13,759 |
2003-07-14 |
0 |
Mckee Blaine H. |
EVP & Chief Business Officer |
2019-07-01 |
5,230 |
2019-07-01 |
0 |
Pien Howard H |
Director |
2009-12-28 |
0 |
2007-05-16 |
0 |
Carter David Warren |
Director |
2010-11-01 |
0 |
2007-04-12 |
0 |
Oleary James J |
Vice President |
2013-07-11 |
0 |
2013-03-07 |
0 |
Perry Gregory D |
Chief Financial Officer |
2013-09-10 |
0 |
2011-06-29 |
0 |
Onetto Nicole |
Director |
2015-06-15 |
0 |
2015-06-15 |
0 |
Mccluski Stephen C |
|
2023-09-13 |
0 |
2023-09-13 |
0 |
Peterson Kristine |
|
2023-11-30 |
0 |
2023-09-13 |
0 |
Vasconcelles Michael |
EVP R&D & MEDICAL AFFAIRS |
2024-02-12 |
0 |
2023-12-29 |
0 |
Goldberg Mark Alan |
Director |
2024-02-12 |
0 |
|
0 |
Mitchell Dean J |
Director |
2024-02-12 |
0 |
2015-11-17 |
0 |
Arbuckle Stuart A |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Wingrove Theresa |
SVP OF REGULATORY AFFAIRS |
2024-02-12 |
0 |
2014-01-10 |
0 |
Coen Stacy Ann |
SVP & CHIEF BUSINESS OFFICER |
2024-02-12 |
0 |
2021-12-31 |
0 |
Wallace Richard John |
Director |
2024-02-12 |
0 |
2023-11-07 |
0 |
Thackray Helen M. |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Lentini Renee |
VP & PRIN ACCTG OFFICER |
2024-02-12 |
0 |
|
0 |
Char Daniel |
SVP & CHIEF LEGAL OFFICER |
2024-02-12 |
0 |
|
0 |
Enyedy Mark J |
CHIEF EXECUTIVE OFFICER, Director |
2024-02-12 |
0 |
|
0 |
Poole Sandra |
|
|
0 |
|
0 |
Harrison Ellie |
|
|
0 |
|
0 |
|
|